Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This distinction matters because the two causes respond to different interventions
Pillar 4: GLP-1 receptor agonists and dual agonists GLP-1-based therapies (such as semaglutide and tirzepatide) are a legitimate pillar for insulin resistance management when obesity and/or appetite dysregulation are part of the picture
If you are already on a GLP-1 medication from another provider, you can maintain your current dose with documentation of your prior prescription
Through this mechanism, tirzepatide helps regulate your blood sugar and lower your appetite by encouraging more insulin release, decreasing glucose production, and slowing gastric emptying (i.e., the movement of food through the digestive tract)
US$ 28.53
US$ 23.17
US$ 24.73
US$ 22.91
